Targeting Metacognitive Change Mechanisms in Acute Inpatients with Psychotic Symptoms: Feasibility and Acceptability of a Modularized Group Intervention

Overview

Journal Eur Arch Psychiatry Clin Neurosci

Specialties Neurology
Psychiatry

Date 2023 Sep 23

PMID 37741946

Authors

Eva Gussmann

Christoph Lindner

Susanne Lucae

Peter Falkai

Frank Padberg

Samy Egli

Johannes Kopf-Beck

Affiliations

Soon will be listed here.

Abstract

Emerging evidence suggests the usefulness of psychological interventions targeting metacognitive change mechanisms in patients experiencing psychosis. Although many of these patients are treated in acute psychiatric contexts, only few studies have adapted such interventions for acute inpatient settings. The present study aimed to assess the feasibility, acceptability, and preliminary clinical outcomes of a novel modularized group intervention focusing on different aspects of metacognitive change mechanisms. In particular, the intervention aims to reduce patients' acute symptoms by enhancing cognitive insight and to relieve distress via cognitive defusion (i.e. coping). A sample of 37 participants with acute psychosis received up to nine sessions of the intervention. Baseline and post-intervention assessments were conducted for general psychopathology, psychotic symptoms, global functioning, and symptom distress. Measures of change mechanisms were assessed before and after the respective treatment module. Participants' experiences were explored in feedback questionnaires and interviews. Recruitment, retention, and attendance rate met the pre-set feasibility benchmark of 80%. The intervention was well received by participants, who emphasised the group's clear structure, positive atmosphere, and helpful contents. Response rates were high and linear mixed models revealed significant medium-to-large time effects on all clinical outcomes. As expected, increase in hypothesised change mechanisms cognitive insight and decrease in cognitive fusion was found. However, the uncontrolled design limits interpreting clinical effects. The study provides evidence that an intervention based on a metacognitive model is feasible and acceptable for acute inpatients with psychosis. Positive results on clinical outcomes and change mechanisms warrant further exploration in a randomized controlled trial.

References

Garety P, Waller H, Emsley R, Jolley S, Kuipers E, Bebbington P . Cognitive mechanisms of change in delusions: an experimental investigation targeting reasoning to effect change in paranoia. Schizophr Bull. 2014; 41(2):400-10. PMC: 4332945. DOI: 10.1093/schbul/sbu103. View

Philippot P, Bouvard M, Baeyens C, Dethier V . Case conceptualization from a process-based and modular perspective: Rationale and application to mood and anxiety disorders. Clin Psychol Psychother. 2018; 26(2):175-190. DOI: 10.1002/cpp.2340. View

McCutcheon R, Marques T, Howes O . Schizophrenia-An Overview. JAMA Psychiatry. 2019; 77(2):201-210. DOI: 10.1001/jamapsychiatry.2019.3360. View

Jacobsen P, Peters E, Robinson E, Chadwick P . Mindfulness-based crisis interventions (MBCI) for psychosis within acute inpatient psychiatric settings; a feasibility randomised controlled trial. BMC Psychiatry. 2020; 20(1):193. PMC: 7191699. DOI: 10.1186/s12888-020-02608-x. View

Moritz S, Veckenstedt R, Bohn F, Hottenrott B, Scheu F, Randjbar S . Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia. Schizophr Res. 2013; 151(1-3):61-9. DOI: 10.1016/j.schres.2013.10.007. View

Wood L, Williams C, Billings J, Johnson S . The therapeutic needs of psychiatric in-patients with psychosis: A qualitative exploration of patient and staff perspectives. BJPsych Open. 2019; 5(3):e45. PMC: 6537445. DOI: 10.1192/bjo.2019.33. View

Marder S, Meibach R . Risperidone in the treatment of schizophrenia. Am J Psychiatry. 1994; 151(6):825-35. DOI: 10.1176/ajp.151.6.825. View

Holmberg C, Gremyr A, Torgerson J, Mehlig K . Clinical validity of the 12-item WHODAS-2.0 in a naturalistic sample of outpatients with psychotic disorders. BMC Psychiatry. 2021; 21(1):147. PMC: 7945302. DOI: 10.1186/s12888-021-03101-9. View

Avery K, Williamson P, Gamble C, OConnell Francischetto E, Metcalfe C, Davidson P . Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ Open. 2017; 7(2):e013537. PMC: 5318608. DOI: 10.1136/bmjopen-2016-013537. View

10.

Kazdin A . Mediators and mechanisms of change in psychotherapy research. Annu Rev Clin Psychol. 2007; 3:1-27. DOI: 10.1146/annurev.clinpsy.3.022806.091432. View

11.

van der Post L, Peen J, Visch I, Mulder C, Beekman A, Dekker J . Patient perspectives and the risk of compulsory admission: the Amsterdam Study of Acute Psychiatry V. Int J Soc Psychiatry. 2013; 60(2):125-33. DOI: 10.1177/0020764012470234. View

12.

Leucht S, Davis J, Engel R, Kissling W, Kane J . Definitions of response and remission in schizophrenia: recommendations for their use and their presentation. Acta Psychiatr Scand Suppl. 2009; (438):7-14. DOI: 10.1111/j.1600-0447.2008.01308.x. View

13.

Bacon T, Farhall J, Fossey E . The active therapeutic processes of acceptance and commitment therapy for persistent symptoms of psychosis: clients' perspectives. Behav Cogn Psychother. 2013; 42(4):402-20. DOI: 10.1017/S1352465813000209. View

14.

Hazell C, Hayward M, Cavanagh K, Strauss C . A systematic review and meta-analysis of low intensity CBT for psychosis. Clin Psychol Rev. 2016; 45:183-92. DOI: 10.1016/j.cpr.2016.03.004. View

15.

Freeman D . Improving cognitive treatments for delusions. Schizophr Res. 2011; 132(2-3):135-9. DOI: 10.1016/j.schres.2011.08.012. View

16.

Gaudiano B, Herbert J . Acute treatment of inpatients with psychotic symptoms using Acceptance and Commitment Therapy: pilot results. Behav Res Ther. 2005; 44(3):415-37. DOI: 10.1016/j.brat.2005.02.007. View

17.

Carballedo A, Doyle M . Criteria for compulsory admission in some European countries. Int Psychiatry. 2019; 8(3):68-71. PMC: 6735031. View

18.

Schlier B, Ludwig L, Wiesjahn M, Jung E, Lincoln T . Fostering coping as a mechanism of symptom change in cognitive behavioural therapy for psychosis. Schizophr Res. 2019; 215:416-423. DOI: 10.1016/j.schres.2019.07.047. View

19.

Mas-Exposito L, Amador-Campos J, Gomez-Benito J, Lalucat-Jo L . The World Health Organization Short Disability Assessment Schedule: a validation study in patients with schizophrenia. Compr Psychiatry. 2011; 53(2):208-16. DOI: 10.1016/j.comppsych.2011.02.009. View

20.

Linden M . How to define, find and classify side effects in psychotherapy: from unwanted events to adverse treatment reactions. Clin Psychol Psychother. 2012; 20(4):286-96. DOI: 10.1002/cpp.1765. View